$0.9580
-0.02-2.24%
Pre-Market: 6:19 PM EDT
Comments
Loading...
Adial Pharmaceuticals (NASDAQ:ADIL) Stock, Earnings Estimates, EPS, And Revenue
Adial Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 31
EPS Estimate
$-0.330
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Adial Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Adial Pharmaceuticals (ADIL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.38 | $-0.41 | 7.32 % |
| Q1 | 2024-05-14 | $-2.19 | $-0.35 | -525.7 % |
| Q4 | 2024-04-01 | $-0.37 | $-0.47 | 21.3 % |
| Q3 | 2023-11-14 | $-1.14 | $-1.13 | -0.88 % |
Adial Pharmaceuticals (ADIL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Adial Pharmaceuticals (NASDAQ:ADIL) reporting earnings?
Adial Pharmaceuticals (ADIL) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Adial Pharmaceuticals (NASDAQ:ADIL)?
The Actual EPS was $-0.38, which beat the estimate of $-0.41.
What were Adial Pharmaceuticals’s (NASDAQ:ADIL) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.